Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 210 resultater
Tid
Selskap
Tittel
Sektor
Kategori
08 Nov 2024
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of October 31st, 2024
20103010 Biotechnology
Other subject
08 Nov 2024
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 octobre 2024
20103010 Biotechnology
Other subject
30 Oct 2024
18:00 CET
ADOCIA
ADOCIA publie ses résultats financiers du troisième trimestre 2024 et fait le point sur ses activités
20103010 Biotechnology
Other subject
30 Oct 2024
18:00 CET
ADOCIA
ADOCIA Reports Third Quarter 2024 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
15 Oct 2024
08:00 CEST
ADOCIA
ADOCIA Announces Patenting Stable Combinations of GLP-1 and Amylin Analogs for the Treatment of Obesity and Diabetes Using Its BioChaperone® Platform
20103010 Biotechnology
Other subject
15 Oct 2024
08:00 CEST
ADOCIA
ADOCIA annonce breveter des combinaisons stables d’analogues de GLP-1 et d’amyline pour le traitement de l’obésité et du diabète grâce à sa plateforme BioChaperone®
20103010 Biotechnology
Other subject
08 Oct 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 septembre 2024
20103010 Biotechnology
Other subject
08 Oct 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of September 30th, 2024
20103010 Biotechnology
Other subject
23 Sep 2024
18:00 CEST
ADOCIA
ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer
20103010 Biotechnology
Other subject
23 Sep 2024
18:00 CEST
ADOCIA
ADOCIA annonce la nomination de Mathieu‑William Gilbert au poste de Directeur Administratif et Financier
20103010 Biotechnology
Other subject
20 Sep 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 août 2024
20103010 Biotechnology
Other subject
20 Sep 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of August 31st, 2024
20103010 Biotechnology
Other subject
19 Sep 2024
18:00 CEST
ADOCIA
ADOCIA Announces First Half 2024 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
19 Sep 2024
18:00 CEST
ADOCIA
ADOCIA publie ses résultats financiers du premier semestre 2024 et dresse un bilan de ses activités
20103010 Biotechnology
Other subject
30 Aug 2024
08:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of July 31st, 2024
20103010 Biotechnology
Other subject
30 Aug 2024
08:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 juillet 2024
20103010 Biotechnology
Other subject
29 Aug 2024
18:00 CEST
ADOCIA
ADOCIA annonce des présentations orales sur AdoShell® et AdoGel® au congrès annuel de l’EASD
20103010 Biotechnology
Other subject
29 Aug 2024
18:00 CEST
ADOCIA
ADOCIA to Deliver Oral Presentations on AdoShell® and AdoGel® at EASD Annual Meeting
20103010 Biotechnology
Other subject
24 Jul 2024
18:37 CEST
ADOCIA
ADOCIA Reports Second Quarter 2024 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
24 Jul 2024
18:37 CEST
ADOCIA
ADOCIA publie ses résultats financiers du second trimestre 2024 et fait le point sur ses activités
20103010 Biotechnology
Other subject
19 Jul 2024
18:00 CEST
ADOCIA
ADOCIA Announces Half Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
20103010 Biotechnology
Other subject
19 Jul 2024
18:00 CEST
ADOCIA
ADOCIA annonce le bilan semestriel du contrat de liquidité conclu avec la société Kepler Capital Markets
20103010 Biotechnology
Other subject
11 Jul 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 Juin 2024
20103010 Biotechnology
Other subject
11 Jul 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of June 30th, 2024
20103010 Biotechnology
Other subject
10 Jul 2024
08:45 CEST
ADOCIA
ADOCIA annonce que Tonghua Dongbao met fin à un des deux programmes en partenariat : BioChaperone® Combo
20103010 Biotechnology
Alliances and agreements
10 Jul 2024
08:45 CEST
ADOCIA
ADOCIA Announces That Tonghua Dongbao Is Discontinuing One of the Two Partnership Programs: BioChaperone® Combo
20103010 Biotechnology
Alliances and agreements
18 Jun 2024
18:19 CEST
ADOCIA
ADOCIA annonce trois présentations lors des 84ème sessions scientifiques de l'American Diabetes Association
20103010 Biotechnology
Other subject
18 Jun 2024
18:19 CEST
ADOCIA
ADOCIA Announces Three Presentations at the American Diabetes Association 84th Scientific Sessions
20103010 Biotechnology
Other subject
17 Jun 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of May 31st, 2024
20103010 Biotechnology
Other subject
17 Jun 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mai 2024
20103010 Biotechnology
Other subject
06 Jun 2024
18:00 CEST
ADOCIA
ADOCIA Confirms Its Eligibility for the PEA–PME
20103010 Biotechnology
Other subject
06 Jun 2024
18:00 CEST
ADOCIA
ADOCIA confirme son éligibilité au PEA-PME
20103010 Biotechnology
Other subject
03 Jun 2024
18:00 CEST
ADOCIA
ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Operating Officer
20103010 Biotechnology
Other subject
03 Jun 2024
18:00 CEST
ADOCIA
ADOCIA annonce la nomination de Mathieu‑William Gilbert au poste de Directeur des Opérations
20103010 Biotechnology
Other subject
23 May 2024
18:00 CEST
ADOCIA
ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 13th, 2024 in Paris
20103010 Biotechnology
Other subject
23 May 2024
18:00 CEST
ADOCIA
ADOCIA annonce la tenue de son assemblée générale annuelle le 13 juin 2024 à Paris
20103010 Biotechnology
Other subject
15 May 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of April 30th, 2024
20103010 Biotechnology
Other subject
15 May 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 avril 2024
20103010 Biotechnology
Other subject
14 May 2024
18:00 CEST
ADOCIA
ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
14 May 2024
18:00 CEST
ADOCIA
ADOCIA publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités
20103010 Biotechnology
Other subject
29 Apr 2024
18:00 CEST
ADOCIA
ADOCIA annonce la mise à disposition de son Document d’Enregistrement Universel pour l’année 2023
20103010 Biotechnology
Other subject
29 Apr 2024
18:00 CEST
ADOCIA
ADOCIA Announces the Release of Its Universal Registration Document for the Year 2023
20103010 Biotechnology
Other subject
24 Apr 2024
18:00 CEST
ADOCIA
ADOCIA Announces Full Year 2023 Financial Results and Provides a Corporate and Financial Update
20103010 Biotechnology
Other subject
24 Apr 2024
18:00 CEST
ADOCIA
ADOCIA annonce ses résultats annuels 2023 et fait le point sur ses activités et sa situation financière à date
20103010 Biotechnology
Other subject
12 Apr 2024
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 mars 2024
20103010 Biotechnology
Other subject
12 Apr 2024
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of March 31st, 2024
20103010 Biotechnology
Other subject
21 Mar 2024
21:40 CET
ADOCIA
ADOCIA Announces a €2 Million Fundraising from its two Main Shareholders and a Member of its Management, and the Signature of an Equity Financing Line with Vester Finance
20103010 Biotechnology
Other subject
21 Mar 2024
21:40 CET
ADOCIA
ADOCIA annonce une levée de fonds de 2 millions d’euros auprès de ses deux actionnaires principaux et un membre de sa Direction, ainsi que la signature d’une ligne de financement en fonds propres avec Vester Finance
20103010 Biotechnology
Other subject
15 Mar 2024
18:00 CET
ADOCIA
Number of Shares and Voting Rights of Adocia as of February 29th, 2024
20103010 Biotechnology
Other subject
15 Mar 2024
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 29 février 2024
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva